首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1392091

马来酸丙氯拉嗪市场：按适应症、按剂型、按配销通路、按地区

Prochlorperazine Maleate Market, By Indication, By Dosage Form, By Distribution Channel, By End User, By Geography

出版日期: 2023年11月16日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年全球马来酸丙氯拉嗪市场规模为14.6亿美元，预计2030年将达到18.5亿美元，2023年至2030年复合年增长率为3.4%，预计还会成长。

报告范围		报告详情
基准年	2022年	2023年市场规模	14.6亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	3.40%	2030年市场规模预测	18.5亿美元

图 1. 马来酸丙氯拉嗪全球市场占有率(%)（按地区），2023 年

马来酸丙氯拉嗪用于治疗严重噁心和呕吐，并改善思觉失调症和焦虑症患者的情绪、思维和行为。它是吩噻嗪类药物的一种。这种药物的作用原理是透过影响大脑化学物质。因此，您的身体可能会产生更多的多巴胺，这是一种有助于运动和愉悦的神经传导物质。它还可能掩盖导致噁心和呕吐的更严重的疾病，例如药物过量摄取或中毒、脑肿瘤、脑损伤和雷氏症候群。吩噻嗪类抗精神病药物之一是马来酸丙氯拉嗪。

市场动态：

在预测期内，呕吐和噁心频率的增加将继续推动全球马来酸丙氯拉嗪市场的成长。由于慢性病的增加和高龄化，需要止吐治疗的人数正在增加。此外，患者意识的提高也将在预测期内继续推动马来酸丙氯拉嗪全球市场的成长。患者越来越愿意寻找合适的替代疗法并与医疗保健提供者讨论他们的问题。在预测期内，联合治疗的创建可能为全球马来酸丙氯拉嗪市场创造新的机会。含有马来酸丙氯拉嗪的组合药物的研究具有市场成长潜力。

预计安全问题和负面副作用将阻碍预测期内马来酸丙氯拉嗪全球市场的成长。

本研究的主要特点

本报告对全球马来酸丙氯拉嗪市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年增长率。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
根据公司亮点、产品系列、主要亮点、业绩和策略等参数对全球马来酸丙氯拉嗪市场的主要企业进行了介绍。
该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
马来酸丙氯拉嗪全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过分析全球马来酸丙氯拉嗪市场时所使用的各种策略矩阵，将有助于相关人员做出决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 1.46 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	3.40%	2030 Value Projection:	US$ 1.85 Bn

Prochlorperazine maleate is utilized for treating severe nausea and vomiting as well as to help people with schizophrenia or anxiety have better moods, thinking, and conduct. It is a member of the phenothiazine class of drugs. The way this drug affects brain chemistry is how it functions. Dopamine, a neurotransmitter that aids in movement and pleasure, might then be produced in greater amounts by the body as a result. It can also mask more serious illnesses that produce nausea and vomiting, such as drug overdose or poisoning, brain tumors, brain injuries, or Reye's syndrome. A medicine from the phenothiazine class of antipsychotics is called prochlorperazine maleate.

Market Dynamics:

The increasing frequency of vomiting and nausea will continue to fuel growth of the global prochlorperazine maleate market over the forecast period. The number of people requiring antiemetic therapy is rising as a result of rising chronic disease prevalence and an aging population. Growing patient awareness will also continue to fuel growth of the global prochlorperazine maleate market over the forecast period. Patients are more active in seeking out the right therapy alternatives and talking about their issues with medical providers. The creation of combination therapies will create new opportunities for the global prochlorperazine maleate market over the forecast period. There is potential for market growth in the investigation of combination medicines containing prochlorperazine maleate.

Safety issues and negative side effects are expected to hamper growth of the global prochlorperazine maleate market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global prochlorperazine maleate market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prochlorperazine maleate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Pfizer Inc., Novartis AG, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Johnson & Johnson, AbbVie Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Lupin Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prochlorperazine maleate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prochlorperazine maleate market

Global Prochlorperazine Maleate Market Detailed Segmentation:

By Indication:
- Nausea and Vomiting Management
- Vertigo
- Mental Health Disorders (e.g., Schizophrenia)
By Dosage Form:
- Oral Tablets
- Rectal Suppositories
- Injectable Formulations
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Homecare Settings
By Regions:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profile:
- GlaxoSmithKline plc
- Pfizer Inc.
- Novartis AG
- AstraZeneca plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sanofi S.A.
- Johnson & Johnson
- AbbVie Inc.
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
- Lupin Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Prochlorperazine Maleate, By Indication
- Market Prochlorperazine Maleate, By Dosage Form
- Market Prochlorperazine Maleate, By Distribution Channel
- Market Prochlorperazine Maleate, By End User
- Market Prochlorperazine Maleate, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Prochlorperazine Maleate Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Prochlorperazine Maleate Market , By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Nausea and Vomiting Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Motion Sickness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Prochlorperazine Maleate Market , By Dosage Form, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Rectal Suppositories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Injectable Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Prochlorperazine Maleate Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Prochlorperazine Maleate Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030,(US$ Bn)
North Africa
South Africa
Central Africa

9. Competitive Landscape

Sandoz Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan Pharmaceuticals Inc.
ABneal Pharmaceuticals LLC
Glenmark Pharmaceuticals Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
Aspen Pharma Trading Limited
FAGRON
Sanofi
GlaxoSmithKline
Hikma Pharmaceuticals
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

马来酸丙氯拉嗪市场：按适应症、按剂型、按配销通路、按地区